de JP Morgan Chase Ionis Pharmaceuticals IONS Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 216 M | Comprar |
2,671,717
+308,150
| +13% | +USD 23.2 M | 0.01% | 727 |
|
|
2026
Q1 | USD 171 M | Comprar |
2,363,567
+58,775
| +3% | +USD 4.64 M | 0.01% | 760 |
|
|
2025
Q4 | USD 182 M | Comprar |
2,304,792
+1,760,324
| +323% | +USD 133 M | 0.01% | 701 |
|
|
2025
Q3 | USD 35.6 M | Comprar |
544,468
+149,490
| +38% | +USD 7.3 M | ﹤0.01% | 1642 |
|
|
2025
Q2 | USD 15.6 M | Vender |
394,978
-26,533
| -6% | -USD 868 k | ﹤0.01% | 2150 |
|
|
2025
Q1 | USD 12.7 M | Comprar |
421,511
+5,592
| +1% | +USD 183 k | ﹤0.01% | 2334 |
|
|
2024
Q4 | USD 14.5 M | Vender |
415,919
-152,987
| -27% | -USD 5.72 M | ﹤0.01% | 2342 |
|
|
2024
Q3 | USD 22.8 M | Vender |
568,906
-25,185
| -4% | -USD 1.17 M | ﹤0.01% | 1876 |
|
|
2024
Q2 | USD 28.3 M | Vender |
594,091
-36,888
| -6% | -USD 1.51 M | ﹤0.01% | 1598 |
|
|
2024
Q1 | USD 27.4 M | Vender |
630,979
-310,053
| -33% | -USD 14.8 M | ﹤0.01% | 1673 |
|
|
2023
Q4 | USD 47.6 M | Comprar |
941,032
+39,975
| +4% | +USD 1.91 M | ﹤0.01% | 1251 |
|
|
2023
Q3 | USD 40.9 M | Vender |
901,057
-166,666
| -16% | -USD 6.88 M | ﹤0.01% | 1211 |
|
|
2023
Q2 | USD 43.8 M | Comprar |
1,067,723
+10,328
| +1% | +USD 397 k | ﹤0.01% | 1176 |
|
|
2023
Q1 | USD 37.8 M | Comprar |
1,057,395
+87,085
| +9% | +USD 3.27 M | ﹤0.01% | 1236 |
|
|
2022
Q4 | USD 36.6 M | Comprar |
970,310
+41,558
| +4% | +USD 1.75 M | ﹤0.01% | 1267 |
|
|
2022
Q3 | USD 41.1 M | Vender |
928,752
-110,818
| -11% | -USD 4.67 M | 0.01% | 1144 |
|
|
2022
Q2 | USD 38.5 M | Vender |
1,039,570
-141,987
| -12% | -USD 5.35 M | 0.01% | 1185 |
|
|
2022
Q1 | USD 43.8 M | Vender |
1,181,557
-87,095
| -7% | -USD 2.85 M | 0.01% | 1239 |
|
|
2021
Q4 | USD 38.6 M | Vender |
1,268,652
-1,147,661
| -47% | -USD 36.1 M | ﹤0.01% | 1354 |
|
|
2021
Q3 | USD 81 M | Comprar |
2,416,313
+140,607
| +6% | +USD 5.3 M | 0.01% | 965 |
|
|
2021
Q2 | USD 90.8 M | Comprar |
2,275,706
+312,483
| +16% | +USD 12.2 M | 0.01% | 948 |
|
|
2021
Q1 | USD 88.3 M | Comprar |
1,963,223
+89,891
| +5% | +USD 5.01 M | 0.01% | 905 |
|
|
2020
Q4 | USD 106 M | Comprar |
1,873,332
+1,145,403
| +157% | +USD 57.1 M | 0.02% | 759 |
|
|
2020
Q3 | USD 35.3 M | Comprar |
727,929
+209,760
| +40% | +USD 11.7 M | 0.01% | 1156 |
|
|
2020
Q2 | USD 30.6 M | Comprar |
518,169
+246,447
| +91% | +USD 13.7 M | 0.01% | 1112 |
|
|
2020
Q1 | USD 12.8 M | Vender |
271,722
-265,229
| -49% | -USD 14.8 M | ﹤0.01% | 1544 |
|
|
2019
Q4 | USD 32.4 M | Comprar |
536,951
+321,660
| +149% | +USD 19.2 M | 0.01% | 1219 |
|
|
2019
Q3 | USD 12.9 M | Comprar |
215,291
+36,553
| +20% | +USD 2.38 M | ﹤0.01% | 1933 |
|
|
2019
Q2 | USD 11.6 M | Comprar |
178,738
+166,696
| +1,384% | +USD 11.8 M | ﹤0.01% | 1986 |
|
|
2019
Q1 | USD 978 k | Vender |
12,042
-136,616
| -92% | -USD 8.81 M | ﹤0.01% | 3819 |
|
|
2018
Q4 | USD 8.04 M | Comprar |
148,658
+138,181
| +1,319% | +USD 7.05 M | ﹤0.01% | 2195 |
|
|
2018
Q3 | USD 541 k | Vender |
10,477
-1,037
| -9% | -USD 48.7 k | ﹤0.01% | 4241 |
|
|
2018
Q2 | USD 480 k | Comprar |
11,514
+6,058
| +111% | +USD 269 k | ﹤0.01% | 4195 |
|
|
2018
Q1 | USD 240 k | Vender |
5,456
-56,651
| -91% | -USD 2.88 M | ﹤0.01% | 4307 |
|
|
2017
Q4 | USD 3.12 M | Vender |
62,107
-465
| -0.7% | -USD 25.5 k | ﹤0.01% | 3035 |
|
|
2017
Q3 | USD 3.29 M | Comprar |
62,572
+60,763
| +3,359% | +USD 3.18 M | ﹤0.01% | 2863 |
|
|
2017
Q2 | USD 92 k | Comprar |
1,809
+894
| +98% | +USD 41.6 k | ﹤0.01% | 4202 |
|
|
2017
Q1 | USD 37 k | Vender |
915
-360
| -28% | -USD 16.2 k | ﹤0.01% | 4600 |
|
|
2016
Q4 | USD 61 k | Vender |
1,275
-3,543
| -74% | -USD 140 k | ﹤0.01% | 4508 |
|
|
2016
Q3 | USD 177 k | Vender |
4,818
-43,141
| -90% | -USD 1.35 M | ﹤0.01% | 3726 |
|
|
2016
Q2 | USD 1.12 M | Comprar |
47,959
+39,420
| +462% | +USD 1.27 M | ﹤0.01% | 3115 |
|
|
2016
Q1 | USD 346 k | Comprar |
8,539
+6,539
| +327% | +USD 266 k | ﹤0.01% | 3463 |
|
|
2015
Q4 | USD 123 k | Vender |
2,000
-9,822
| -83% | -USD 530 k | ﹤0.01% | 3749 |
|
|
2015
Q3 | USD 478 k | Vender |
11,822
-30,279
| -72% | -USD 1.57 M | ﹤0.01% | 3432 |
|
|
2015
Q2 | USD 2.42 M | Vender |
42,101
-302,805
| -88% | -USD 19.3 M | ﹤0.01% | 2797 |
|
|
2015
Q1 | USD 22 M | Vender |
344,906
-21,400
| -6% | -USD 1.45 M | 0.01% | 1374 |
|
|
2014
Q4 | USD 22.6 M | Comprar |
366,306
+8,731
| +2% | +USD 431 k | 0.01% | 1393 |
|
|
2014
Q3 | USD 13.9 M | Comprar |
357,575
+94,258
| +36% | +USD 3.34 M | ﹤0.01% | 1689 |
|
|
2014
Q2 | USD 9.07 M | Vender |
263,317
-93,232
| -26% | -USD 2.94 M | ﹤0.01% | 1796 |
|
|
2014
Q1 | USD 15.4 M | Comprar |
356,549
+341,761
| +2,311% | +USD 16.6 M | ﹤0.01% | 1483 |
|
|
2013
Q4 | USD 589 k | Vender |
14,788
-44,325
| -75% | -USD 1.58 M | ﹤0.01% | 3406 |
|
|
2013
Q3 | USD 2.22 M | Vender |
59,113
-50,890
| -46% | -USD 1.52 M | ﹤0.01% | 2742 |
|
|
2013
Q2 | USD 2.96 M | Comprar |
+110,003
| Nuevas | +USD 2.34 M | ﹤0.01% | 2517 |
|
Otros fondos que tienen IONS en su cartera
Posición de JP Morgan Chase en IONS: resumen de T2 2026
JP Morgan Chase aumentó su participación en Ionis Pharmaceuticals (IONS) en 13% durante T2 2026, al comprar aproximadamente USD 23.2 M y elevar la posición a 2,671,717 acciones con un valor de USD 216 M. La posición representa 0.01% de la cartera y ocupa el puesto #727.
JP Morgan Chase reportó por primera vez una posición en IONS en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 516 fondos que sigue Wall St. Rank mantienen una posición en IONS.
- Al cierre de T2 2026, JP Morgan Chase tenía 2,671,717 acciones de Ionis Pharmaceuticals con un valor de USD 216 M.
- JP Morgan Chase compró 308,150 acciones de Ionis Pharmaceuticals en T2 2026, por un monto estimado de USD 23.2 M.
- Ionis Pharmaceuticals representó 0.01% de la cartera de JP Morgan Chase en T2 2026 y fue su posición número 727.
- JP Morgan Chase reportó por primera vez una posición en Ionis Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 516 fondos que sigue Wall St. Rank tenían Ionis Pharmaceuticals en cartera.
Según el Informe 13F de JP Morgan Chase correspondiente a T2 2026, presentado el 12 ago 2026.